Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis
- PMID: 10694562
- DOI: 10.1200/JCO.2000.18.5.1094
Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis
Abstract
Purpose: The optimum management of hepatocellular carcinoma (HCC) associated with cirrhosis has not yet been clarified. Very few data are available in the literature regarding the prognosis after resection of HCC associated with hepatitis B virus (HBV)-related cirrhosis. This study evaluated the long-term results and prognostic factors after resection of HCC complicating HBV-related cirrhosis.
Patients and methods: One hundred forty-six patients with HBV-related Child's A or B cirrhosis who had undergone resection of HCC over a 10-year period were prospectively studied for long-term results. They were compared with 155 noncirrhotic patients with HBV-related HCC resected in the same period.
Results: The overall survival results of cirrhotic patients after resection of HCC were comparable to those of noncirrhotic patients (5-year survival, 44.3% v 45.6%, respectively; P =.216), but the former group had significantly smaller tumors. Stratified according to tumor size, the survival results were similar between cirrhotic and noncirrhotic patients with tumors </= 5 cm (5-year survival, 60.7% v 61.7%, respectively; P =.327) but were worse in cirrhotic compared with noncirrhotic patients with tumors greater than 5 cm (5-year survival, 27.8% v 39.5%, respectively; P =.034). Stage by stage, there were no significant differences in survival results between cirrhotic and noncirrhotic patients. Preoperative serum AST level greater than 100 IU/L (P =.004), perioperative transfusion (P =.015), and venous invasion (P <.001) were independent adverse prognostic factors.
Conclusion: The prognosis after resection of HCCs less than 5 cm in patients with compensated HBV-related cirrhosis was comparable to that of noncirrhotic patients, which suggests that surgical resection may be considered a first-line treatment for these patients. Patients with underlying active hepatitis as indicated by a high preoperative transaminase level are less favorable candidates for resection. Further studies are needed to define the relative roles of resection and transplantation for HCC associated with hepatitis B cirrhosis.
Similar articles
-
Prognosis after resection of hepatitis B virus-related hepatocellular carcinoma originating from non-cirrhotic liver.Ann Surg Oncol. 2014 Jul;21(7):2406-12. doi: 10.1245/s10434-014-3505-0. Epub 2014 Feb 28. Ann Surg Oncol. 2014. PMID: 24577811
-
Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.Ann Surg. 2014 Oct;260(4):650-6; discussion 656-8. doi: 10.1097/SLA.0000000000000917. Ann Surg. 2014. PMID: 25203882
-
Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis.Ann Surg Oncol. 2014 Feb;21(2):458-65. doi: 10.1245/s10434-013-3302-1. Epub 2013 Oct 17. Ann Surg Oncol. 2014. PMID: 24132624
-
Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.J Surg Oncol. 2002 Dec;81(4):195-202. doi: 10.1002/jso.10178. J Surg Oncol. 2002. PMID: 12451624 Review.
-
Hepatocellular cancer: resection or transplantation.J Hepatobiliary Pancreat Surg. 1998;5(1):18-23. doi: 10.1007/pl00009945. J Hepatobiliary Pancreat Surg. 1998. PMID: 9683749 Review.
Cited by
-
Clinicopathological determinants of survival after hepatic resection of hepatocellular carcinoma in 97 patients--experience from an Australian hepatobiliary unit.J Gastrointest Surg. 2010 Sep;14(9):1370-80. doi: 10.1007/s11605-010-1277-9. Epub 2010 Jun 29. J Gastrointest Surg. 2010. PMID: 20585991
-
Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.World J Surg. 2012 Jan;36(1):151-6. doi: 10.1007/s00268-011-1323-0. World J Surg. 2012. PMID: 22030561 Free PMC article.
-
[Radiofrequency ablation of hepatocellular carcinoma].Wien Med Wochenschr. 2013 Mar;163(5-6):132-6. doi: 10.1007/s10354-013-0176-6. Epub 2013 Mar 21. Wien Med Wochenschr. 2013. PMID: 23515886 Review. German.
-
Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival.Ann Surg. 2007 Jan;245(1):51-8. doi: 10.1097/01.sla.0000225255.01668.65. Ann Surg. 2007. PMID: 17197965 Free PMC article.
-
Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.Ann Surg. 2003 Feb;237(2):171-9. doi: 10.1097/01.SLA.0000048443.71734.BF. Ann Surg. 2003. PMID: 12560774 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical